A novel role for interleukin-18 in human natural killer cell death: High serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases

Arthritis and Rheumatism

Volumn 44, Issue 4, 2001, Pages 884-892

  Shibatomi, Kazutaka ^a   Ida, Hiroaki ^a   Yamasaki, Satoshi ^a   Nakashima, Tomoki ^a   Origuchi, Tomoki ^a   Kawakami, Atsushi ^b   Migita, Kiyoshi ^b   Kawabe, Yojiro ^c   Tsujihata, Mitsuhiro ^c   Anderson, Paul ^c   Eguchi, Katsumi ^c  

^a NAGASAKI UNIVERSITY   (Japan)

^b Nagasaki Kita Hospital   (Japan)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DIHEXYLOXACARBOCYANINE; CASPASE 3; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; PROPIDIUM IODIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; APOPTOSIS; AUTOIMMUNE DISEASES; CASPASE 3; CASPASES; CELL COUNT; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-18; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035046451     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200104)44:4<884::AID-ANR145>3.0.CO;2-4     Document Type: Article

References (37)

1. Biology of human natural killer cells
2. NK cell receptors
3. The development of autoimmunity in C57BL/6 1pr mice correlates with the disappearance of natural killer type-1-positive cells: Evidence for their suppressive action on bone marrow stem cell proliferation, B cell immunoglobulin secretion, and autoimmune symptoms
4. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells
5. The immunoregulatory effects of NK cells: The role of TGF-β and implications for autoimmunity
6. + T cells in a transfer model of colitis
7. Inhibition of autoimmune T celt responses in the DA rat by bone marrow-derived NK cells in vitro: Implications for autoimmunity
8. In vivo natural killer celt activities revealed by natural killer cell-deficient mice
9. Natural killer cells and natural killer T cells
10. Natural killer cells in antiviral defense: Function and regulation by innate cytokines
11. Role of cytokines in rheumatoid arthritis
12. Cloning of a new cytokine that induces IFN-γ production by T cells
13. Interleukin-18
14. Receptor-induced death in human natural killer cells: Involvement of CD16
15. Ligand binding of FcγR induces c-myc-dependent apoptosis in IL-2-stimulated NK cells
16. CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells
17. Activation-induced NK cell death triggered by CD2 stimulation
18. Cytokine-induced apoptosis of human natural killer cells identifies a novel mechanism to regulate the innate immune response
19. + cells in the peripheral blood and thyroid tissue of patients with Graves' disease
20. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains
21. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo
22. Regulation of synovial cell apoptosis by proteasome inhibitor
23. Nuclear factor-κB and caspases co-operatively regulate the activation and apoptosis of human macrophages
24. Differential cytokine and chemokine gene expression by human NK cells following activation with, IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response
25. Inhibition of caspase cascade by HTLV-I tax through induction of NF-κB nuclear translocation
26. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens
27. A potential role for interleukin-15 in the regulation of human natural killer cell survival
28. Natural killer function in systemic lupus erythematosus
29. Natural killing activity in Sjögrens syndrome: An analysis of defective mechanisms
30. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus
31. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome
32. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease
33. Natural killer cell activity in the systemic connective tissue diseases
34. Natural killer cell number and activity in remission phase of systemic connective tissue diseases
35. Selective reduction of T cells bearing invariant Vα24JαQ antigen receptor in patients with systemic sclerosis
36. Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA)
37. A proinflammatory role for IL-18 in rheumatoid arthritis